CNBCLean R·
Chinese biopharma stocks jump as U.S. weighs keeping door open to drug deals
Chinese biopharma stocks rose on Monday after a report that the U.S. may continue to allow most drug licensing deals with Chinese firms.
Read at CNBC →
BBC
Chinese biopharma stocks rose on Monday after a report that the U.S. may continue to allow most drug licensing deals with Chinese firms.
<iframe src="https://statesidedaily.com/embed/cluster/c00fcbd4202f0749fd0e2ccb2cf0a0fcc77c83e5" width="100%" height="320" style="border:0;max-width:680px" loading="lazy" title="Chinese biopharma stocks jump as U.S. weighs keeping door open to drug deals"></iframe>
